CRL vs UTHR · rev $2.00B vs P/E 20, rev $1.56B
Charles River Laboratories (CRL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CRL currently screens at market cap $7.78B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CRL and UTHR stock pages for the full models.
Not investment advice.